Abstract:Background Sphingolipids produce pleiotropic signaling pathways, and participate in the pathological mechanism of hepatocyte apoptosis and necrosis during liver injury. However, the role of glucosylceramide synthase (GCS)–key enzyme that catalyzes the first glycosylation step, in liver injury is still vague. Methods All experiments were conducted using 7–9-week-old pathogen-free male C57BL/6 mice. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were detected in murine models of liver disease, in addition to histological characterization of liver injuries. Quantitative real-time polymerase chain reaction (qRT-PCR) was used to detect the relative expression of the GCS, matrix metallopeptidase-1 (MMP-1), and tissue inhibitor of metalloproteinase-1 (TIMP-1) genes. The GCS was observed through a fluorescence microscope, and the flow cytometry was used to detect hepatocyte apoptosis. The concentrations of serum IL-4, IL-6, and IL-10 were measured using enzyme-linked immune-sorbent assay (ELISA) kit. MMP-1 and TIMP-1 protein expression was measured via western blot (WB) analysis. Results Con A is often used as a mitogen to activate T lymphocytes and promote mitosis. A single dose of Con A injected intravenously will cause a rapid increase of ALT and AST, which is accompanied by the release of cytokines that cause injury and necrosis of hepatocytes. In this study, we successfully induced acute immune hepatitis in mice by Con A. Con A administration resulted in GCS upregulation in liver tissues. Moreover, the mice in the Con A group had significantly higher levels of ALT, AST, IL-4, IL-6, IL-10 and increased hepatocyte apoptosis than the control group. In contrast, all of the aforementioned genes were significantly downregulated after the administration of a GCS siRNA or Genz-123346 ( i.e. , a glucosylceramide synthase inhibitor) to inhibit the GCS gene. Additionally, the histopathological changes observed herein were consistent with our ALT, AST, IL-4, IL-6, and IL-10 expression results. However, unlike this, hepatocyte apoptosis has been further increased on the basis of the Con A group. Moreover, our qRT-PCR and WB results indicated that the expression of MMP-1 in the Con A group was significantly lower than that in the control group, whereas TIMP-1 exhibited the opposite trend. Conversely, MMP-1 expression in the GCS siRNA and Genz-123346 groups was higher than that in the Con A group, whereas TIMP-1 expression was lower. Conclusions GCS inhibition reduces Con A-induced immune-mediated liver injury in mice, which may be due to the involvement of GCS in the hepatocyte repair process after injury.

Deletion of Cyclic GMP-AMP Synthase Aggravates Concanavalin A-Induced Acute Hepatic Injury by Facilitating Leukocyte Chemotaxis

Glucosylceramide synthase regulates hepatocyte repair after concanavalin A-induced immune-mediated liver injury

The molecular mechanism of acute liver injury and inflammatory response induced by Concanavalin A

CX3CR1 deficiency exacerbates immune-mediated hepatitis by increasing NF-B-mediated cytokine production in macrophage and T cell

Natural Killer T Cells Play a Necessary Role in Modulating of Immune-Mediated Liver Injury by Gut Microbiota

Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell–Mediated Hepatitis Via Compensatory Up-regulation of CXCR2–Related Chemokine Activity

Deficiency of O-linked-glycosylation Regulates Activation of T Cells and Aggravates Concanavalin A-induced Liver Injury

CD8+ T cell/IL-33/ILC2 axis exacerbates the liver injury in Con A-induced hepatitis in T cell-transferred Rag2-deficient mice

[Protective Role of Γδ T Cells in Concanavalin A-induced Liver Injury].

Inducible Nitric Oxide Synthase Regulates Macrophage Polarization Via the MAPK Signals in Concanavalin A‐induced Hepatitis

Multi-Omics Analysis Reveals the Protection of Gasdermin D in Concanavalin A-Induced Autoimmune Hepatitis

Lamina Propria Interleukin 17 A Aggravates Natural Killer T-cell Activation in Autoimmune Hepatitis

High-mobility group box 1 exacerbates concanavalin A-induced hepatic injury in mice

Deactivation and apoptosis of hepatic macrophages are involved in the development of concanavalin A‑induced acute liver failure.

Atg7 Knockdown Augments Concanavalin A-Induced Acute Hepatitis Through an ROS-Mediated P38/mapk Pathway.

The Role of Intracellular High-Mobility Group Box 1 in the Early Activation of Kupffer Cells and the Development of Con A-induced Acute Liver Failure

Protective role of cGAS in NASH is related to the maintenance of intestinal homeostasis

Hepatic NK Cell-Mediated Hypersensitivity to ConA-induced Liver Injury in Mouse Liver Expressing Hepatitis C Virus Polyprotein.

Mechanisms of concanavalin A-induced cytokine synthesis by hepatic stellate cells: Distinct roles of interferon regulatory factor-1 in liver injury

Stellate Cells Orchestrate Concanavalin A-Induced Acute Liver Damage

A Microarray Analysis of Early Activated Pathways in Concanavalin A-induced Hepatitis